This preclinical work would suggest that lower DAT availability in humans would be associated with hyperactivity and novelty responding, which are often correlated with impulsivity and are key behavioral hallmarks of ADHD. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.